Chelidamic acid (CAS No 138-60-3) is a compound explored within the biomedical research category for its potential therapeutic applications Originating from studies focused on derivative analogs of known bioactive molecules it primarily targets enzymatic pathways involved in inflammatory and oxidative processes Its mechanism of action involves modulating key biochemical pathways which could influence cellular responses to stress and damage Demonstrating in vitro activity generally in the nanomolar to low micromolar range Chelidamic acid is frequently utilized in cell models and animal studies to assess its efficacy and safety profile These evaluations are critical in drug screening processes to identify potential therapeutic agents Experimental concentrations typically depend on the specific research design making it a versatile option for a wide array of scientific inquiries